These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28378412)

  • 1. Déjà Vu at the FDA.
    Sharfstein J
    Milbank Q; 2017 Jun; 95(2):245-248. PubMed ID: 28378412
    [No Abstract]   [Full Text] [Related]  

  • 2. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT; Hagie F; Keen CL; Gershwin ME
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug development and FDA approval, 1938-2013.
    Darrow JJ; Kesselheim AS
    N Engl J Med; 2014 Jun; 370(26):e39. PubMed ID: 24963591
    [No Abstract]   [Full Text] [Related]  

  • 4. Failing the public health--rofecoxib, Merck, and the FDA.
    Topol EJ
    N Engl J Med; 2004 Oct; 351(17):1707-9. PubMed ID: 15470193
    [No Abstract]   [Full Text] [Related]  

  • 5. Rofecoxib, Merck, and the FDA.
    Kim PS; Reicin AS
    N Engl J Med; 2004 Dec; 351(27):2875-8; author reply 2875-8. PubMed ID: 15625342
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioequivalence: the regulatory career of a pharmaceutical concept.
    Carpenter D; Tobbell DA
    Bull Hist Med; 2011; 85(1):93-131. PubMed ID: 21551918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scott Gottlieb and the Credibility of U.S. Therapeutics.
    Carpenter D
    N Engl J Med; 2017 Apr; 376(15):e30. PubMed ID: 28402242
    [No Abstract]   [Full Text] [Related]  

  • 8. Shifting terrain in the regulation of off-label promotion of pharmaceuticals.
    Mello MM; Studdert DM; Brennan TA
    N Engl J Med; 2009 Apr; 360(15):1557-66. PubMed ID: 19357413
    [No Abstract]   [Full Text] [Related]  

  • 9. 100 years of biologics regulation.
    FDA Consum; 2002; 36(4):8-10. PubMed ID: 12184315
    [No Abstract]   [Full Text] [Related]  

  • 10. Biopharmaceutical statistics in a pharmaceutical regulated environment: past, present, and future.
    Segreti AC; Leung HM; Koch GG; Davis RL; Mohberg NR; Peace KE
    J Biopharm Stat; 2001 Nov; 11(4):347-72. PubMed ID: 12018784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fifty Years of Expert Advice - Pharmaceutical Regulation and the Legacy of the Drug Efficacy Study.
    Schwartz JL
    N Engl J Med; 2016 Nov; 375(21):2015-2017. PubMed ID: 27959733
    [No Abstract]   [Full Text] [Related]  

  • 12. Food and Drug Administration centennial: recognizing the guardians of our drug supply.
    Beary JF
    Arthritis Rheum; 2006 Oct; 54(10):3374. PubMed ID: 17009312
    [No Abstract]   [Full Text] [Related]  

  • 13. The FDA and deference lost: a self-inflicted wound or the product of a wounded agency? A response to Professor O'Reilly.
    Vladeck DC
    Cornell Law Rev; 2008 Jul; 93(5):981-1002. PubMed ID: 18618967
    [No Abstract]   [Full Text] [Related]  

  • 14. A brief history of generic substitution in the USA.
    Sullivan CG
    Pharm Pat Anal; 2012 Mar; 1(1):9-11. PubMed ID: 24236706
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug development history, "overview," and what are GCPs?
    Heilman RD
    Qual Assur; 1995 Mar; 4(1):75-9. PubMed ID: 8520867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access before approval--a right to take experimental drugs?
    Okie S
    N Engl J Med; 2006 Aug; 355(5):437-40. PubMed ID: 16885545
    [No Abstract]   [Full Text] [Related]  

  • 17. Direct-to-consumer prescription drug advertising: history, regulation, and issues.
    Huh J; DeLorme DE; Reid LN; An S
    Minn Med; 2010 Mar; 93(3):50-2. PubMed ID: 20429178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sure cure: public policy on drug efficacy before 1962.
    Swann JP
    Publ Am Inst Hist Pharm; 1997; 16():223-61. PubMed ID: 11619897
    [No Abstract]   [Full Text] [Related]  

  • 19. Food and Drug Administration: 100 years of protection.
    Mosocco DJ
    Home Healthc Nurse; 2007 Mar; 25(3):148-50. PubMed ID: 17353704
    [No Abstract]   [Full Text] [Related]  

  • 20. The courage of one's convictions: the due diligence of Frances Oldham Kelsey at the FDA.
    Scheindlin S
    Mol Interv; 2011 Feb; 11(1):3-9. PubMed ID: 21441115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.